Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-02-16

EMA Authorised: Pregabalin Zentiva (pregabalin) — Zentiva, k.s.

View source ↗

Summary

EMA authorised a generic pregabalin product, Pregabalin Zentiva, for anxiety disorders and epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin Zentiva (pregabalin)

Snippet

Status: Authorised. Therapeutic area: Anxiety Disorders;Epilepsy. MAH: Zentiva, k.s.. Decision date: 13/02/2026